V. Garcia-Larsen (Baltimore, United States of America), J. Soriano (Madrid, Spain)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
The impact of Covid-19 on hospital length of stay and resources: an experience from a tertiary respiratory centre in the UK
R. Wang (Manchester, United Kingdom), D. Mudawi (Manchester, United Kingdom), A. Abdelgabar (Manchester, United Kingdom), K. Heyes (Manchester, United Kingdom), R. Niven (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), R. Wang (Manchester (Greater Manchester), United Kingdom)
|   |
Seroprevalence of anti SARS-CoV-2 antibodies in a random sample of inhabitants of Katowice Region, Poland
G. Brozek (Katowice, Poland), J. Zejda (Katowice, Poland), M. Kowalska (Katowice, Poland), K. Baranski (Katowice, Poland), A. Kaleta-Pilarska (Katowice, Poland), A. Nowakowski (Katowice, Poland)
| |
Data partitioning from the two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience.
G. Stella (Pavia , Italy), P. Davide (Pavia, Italy), F. Albicini (Pavia , Italy), E. Gini (Pavia , Italy), A. Grosso (Pavia , Italy), A. Corsico (Pavia , Italy)
| |
SARS-CoV-2 infections in people with PCD
E. Pedersen (Bern, Switzerland), M. Goutaki (Bern, Switzerland), A. Harris (Southampton, United Kingdom), L. Dixon (London, United Kingdom), M. Manion (Minneapolis, United States of America), B. Rindlisbacher (Steffisburg, Switzerland), J. Lucas (Southampton, United Kingdom), C. Kuehni (Bern, Switzerland)
| |
COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale
S. Ottaviani (Pavia (PV), Italy), I. Ferrarotti (Pavia (PV), Italy), A. Balderacchi (Pavia (PV), Italy), V. Barzon (Pavia (PV), Italy), A. Corino (Pavia (PV), Italy), A. De Silvestri (Pavia (PV), Italy), D. Piloni (Pavia (PV), Italy), F. Mariani (Pavia (PV), Italy), A. Corsico (Pavia (PV), Italy)
| |
Mortality in home mechanical ventilation users during the COVID-19 pandemic
R. D'Cruz (London, United Kingdom), N. Shah (London, United Kingdom), A. Learoyd (London, United Kingdom), O. Elias (London, United Kingdom), M. Mackie (London, United Kingdom), N. Weston (London, United Kingdom), N. Hart (London, United Kingdom), G. Kaltsakas (London, United Kingdom), P. Marino (London, United Kingdom), H. Pattani (London, United Kingdom), M. Ramsay (London, United Kingdom), S. Srivastava (London, United Kingdom), J. Steier (London, United Kingdom), E. Suh (London, United Kingdom), P. Murphy (London, United Kingdom)
| |
Risk factors for COVID-19 sickness absence in healthcare staff
D. van der Plaat (London, United Kingdom), D. Coggon (Southampton, United Kingdom), P. Cullinan (London, United Kingdom), R. Edge (Lancashire, United Kingdom), I. Madan (London, United Kingdom), R. Muiry (London, United Kingdom), V. Parsons (London, United Kingdom), M. Van Tongeren (Manchester, United Kingdom)
| |
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
N. Faria (Porto, Portugal), M. Costa (Porto, Portugal), J. Gomes (Porto, Portugal), M. Sucena (Porto, Portugal)
| |
A study of infection latency and determination of quarantine period in hospital staff with Covid 19
J. T.Kutty (Mumbai (Maharashtra), India), B. Madhav (Mumbai (Maharashtra), India), C. Prakash (Mumbai (Maharashtra), India), N. Patil (Mumbai (Maharashtra), India), D. Dhanwante (Mumbai (Maharashtra), India), D. Revande (Mumbai (Maharashtra), India)
| |
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection
P. Kamstrup (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), N. Hoyer (Hellerup, Denmark), C. Ulrik (Hvidovre, Denmark), L. Pedersen (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), Z. Harboe (Hilleroed, Denmark), U. Bodtger (Naestved, Denmark), R. Bojesen (Slagelse, Denmark), K. Håkansson (Hvidovre, Denmark), C. Tidemandsen (Hvidovre, Denmark), K. Armbruster (Hellerup, Denmark), A. Browatzki (Hilleroed, Denmark), H. Meteran (Hellerup, Denmark), C. Meyer (Roskilde, Denmark), K. Skaarup (Hellerup, Denmark), M. Lassen (Hellerup, Denmark), J. Lundgren (Copenhagen, Denmark), T. Biering-Sørensen (Hellerup, Denmark), J. Jensen (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark)
| |
Prolonged viral RNA shedding in patients with COVID-19 infection
F. Bini (Garbagnate Milanese, Italy), B. Bodini (Garbagnate Milanese, Italy), M. Bongiovanni (Garbagnate Milanese, Italy), A. De Lauretis (Garbagnate Milanese, Italy), S. Zucchetti (Garbagnate Milanese, Italy), U. Zanini (Garbagnate Milanese, Italy)
| |
Excess Mortailty during Covid-19 pandemic in Istanbul
B. Musellim (Istanbul, Turkey), S. Kul (Istanbul, Turkey), P. Ay (Istanbul, Turkey), C. Uyanusta (Istanbul, Turkey), E. Dagli (Istanbul, Turkey), O. Itil (Istanbul, Turkey), H. Bayram (Istanbul, Turkey)
| |
Seroprevalence of anti-SARS-CoV-2 IgG antibody in hospitalized patients: Results of the first hospital-based serosurvey from India
A. Ray (New Delhi, India), K. Singh (New Delhi, India), G. Batra (New Delhi, India), N. Wig (New Delhi, India), N. Vikram (New Delhi, India), S. Chattopadhyay (New Delhi, India), F. Mehdi (New Delhi, India)
| |
COVID 19 in Health Professionals: Profile of 15540 Medical Care and Description of Positive Cases
T. Nery (São Paulo, Brazil), C. Feijó (São Paulo, Brazil), E. Hara (São Paulo, Brazil), F. Viana (São Paulo, Brazil), R. Prestes (São Paulo, Brazil), A. Barboza (São Paulo, Brazil), M. Moreira (São Paulo, Brazil), J. Freitas (São Paulo, Brazil), R. Stelmach (São Paulo, Brazil), U. Santos (São Paulo, Brazil)
| |
How the COVID19 pandemic changed the attitude versus seasonal flu vaccination among COPD patients in Serbia
M. Ilic (Sremska Kamenica (Vojvodina), Republic of Serbia), N. Savic (Sremska Kamenica (Vojvodina), Republic of Serbia), N. Lalic (Sremska Kamenica (Vojvodina), Republic of Serbia), K. Veres (Sremska Kamenica (Vojvodina), Republic of Serbia), J. Javorac (Sremska Kamenica (Vojvodina), Republic of Serbia), I. Kopitovic (Sremska Kamenica (Vojvodina), Republic of Serbia)
| |
Comparison of biopsychosocial and pulmonary short term sequelae between epidemic waves in critical COVID19 patients
P. Carmona Arias (LLEIDA, Spain), S. Santisteve (LLEIDA, Spain), A. Monge (LLEIDA, Spain), A. Moncusi (LLEIDA, Spain), C. Gort (LLEIDA, Spain), I. Benitez (LLEIDA, Spain), D. De Gonzalo (LLEIDA, Spain), G. Torres (LLEIDA, Spain), F. Barbe (LLEIDA, Spain), J. Gonzalez (LLEIDA, Spain)
| |
High Covid-19 mortality in a young population: Istanbul experience
N. Aykac (Istanbul, Turkey), E. Dagli (Istanbul, Turkey), O. Elbek (Istanbul, Turkey)
| |
A method of selecting most significant biochemical parameters in a given clinical setting in COVID-19
S. Purohit Joshi (Jaipur, India), A. Sinha (Hyderabad, India), H. Mishra (Jaipur, India), P. Rijhwani (Jaipur, India), R. Sarkar (London, United Kingdom), P. Sekhar Das (Bangalore, India), S. Jana (Hyderabad, India)
| |
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Moscow city hospital
K. Karnoukh (Moscow, Russian Federation), V. Drozdov (Moscow, Russian Federation), D. Savintseva (Moscow, Russian Federation), N. Lazareva (Moscow, Russian Federation)
| |
Assessment of the role of CT severity score in COVID-19 outcome prediction in a large Indian cohort
S. Purohit Joshi (Jaipur, India), A. Sinha (Hyderabad, India), H. Mishra (Jaipur, India), P. Rijhwani (Jaipur, India), R. Sarkar (Kent, United Kingdom), P. Sekhar Das (Bangalore, India), S. Jana (Hyderabad, India)
| |